fomesafen has been researched along with Lung Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, K; Bernicker, EH; Cagle, PT; Olsen, RJ; Phung, TL; Thomas, JS | 1 |
| Ang, MK; Chan, KS; Chowbay, B; Devanand, A; Fong, KW; Gan, EM; Hsu, AA; Jain, A; Kanesvaran, R; Kim, SW; Koh, T; Koong, HN; Lim, C; Lim, CH; Lim, KH; Lim, WT; Loo, CM; Ng, DZ; Ng, QS; Oon, L; Takano, A; Tan, DS; Tan, EH; Tan, WM; Toh, CK; Yap, SP | 1 |
2 other study(ies) available for fomesafen and Lung Adenocarcinoma
| Article | Year |
|---|---|
Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Prognosis; Reflex; Retrospective Studies | 2020 |
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cohort Studies; Demography; Disease Progression; Disease-Free Survival; DNA Mutational Analysis; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Protein Kinase Inhibitors; Reflex; Smoking; Treatment Outcome | 2015 |